# IMPENDIA- PEN VS Dianeal Only Improved Metabolic Control In Diabetic CAPD and APD Patients

> **NCT00567489** · PHASE4 · COMPLETED · sponsor: **Vantive Health LLC** · enrollment: 137 (actual)

## Conditions studied

- ESRD
- Diabetes
- CAPD
- APD

## Interventions

- **DRUG:** Physioneal
- **DRUG:** Dianeal
- **DRUG:** Extraneal
- **DRUG:** Nutrineal

## Key facts

- **NCT ID:** NCT00567489
- **Lead sponsor:** Vantive Health LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2011-07
- **Final completion:** 2011-07
- **Target enrollment:** 137 (ACTUAL)
- **Last updated:** 2025-07-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00567489

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00567489, "IMPENDIA- PEN VS Dianeal Only Improved Metabolic Control In Diabetic CAPD and APD Patients". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT00567489. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*